Search research articles
Contact Us
Filters
Showing results (621-630 of 632) with videos related to
Page
of 64
Sort By:
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2
Christopher C Arico-Muendel, Dennis R Benjamin, Teresa M Caiazzo, et al.
The Journal of Clinical Investigation
|
December 5, 2009
Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys
Steven E Bosinger, Qingsheng Li, Shari N Gordon, et al.
Molecular Pharmacology
|
April 24, 2014
Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor
R Benjamin Free, Lani S Chun, Amy E Moritz, et al.
Molecular Psychiatry
|
January 11, 2019
New roles for dopamine D<sub>2</sub> and D<sub>3</sub> receptors in pancreatic beta cell insulin secretion
Zachary J Farino, Travis J Morgenstern, Antonella Maffei, et al.
Leukemia
|
April 18, 2002
Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213
R J Wells, D C Arthur, A Srivastava, et al.
Vox Sanguinis
|
December 17, 2013
Should DEHP be eliminated in blood bags?
P F van der Meer, H W Reesink, S Panzer, et al.
Journal of Medicinal Chemistry
|
August 30, 2023
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder
Comfort A Boateng, Ashley N Nilson, Rebekah Placide, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Page
of 64
Search research articles
Search
Showing results (621-630 of 632) with videos related to
Sort By:
Page
of 64
ACS Pharmacology & Translational Science
|
January 19, 2023
Identification and Characterization of ML321: A Novel and Highly Selective D<sub>2</sub> Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity
R Benjamin Free, Ashley N Nilson, Noelia M Boldizsar, et al.
Journal of Medicinal Chemistry
|
November 26, 2009
Carbamate analogues of fumagillin as potent, targeted inhibitors of methionine aminopeptidase-2
Christopher C Arico-Muendel, Dennis R Benjamin, Teresa M Caiazzo, et al.
The Journal of Clinical Investigation
|
December 5, 2009
Global genomic analysis reveals rapid control of a robust innate response in SIV-infected sooty mangabeys
Steven E Bosinger, Qingsheng Li, Shari N Gordon, et al.
Molecular Pharmacology
|
April 24, 2014
Discovery and characterization of a G protein-biased agonist that inhibits β-arrestin recruitment to the D2 dopamine receptor
R Benjamin Free, Lani S Chun, Amy E Moritz, et al.
Molecular Psychiatry
|
January 11, 2019
New roles for dopamine D<sub>2</sub> and D<sub>3</sub> receptors in pancreatic beta cell insulin secretion
Zachary J Farino, Travis J Morgenstern, Antonella Maffei, et al.
Leukemia
|
April 18, 2002
Prognostic variables in newly diagnosed children and adolescents with acute myeloid leukemia: Children's Cancer Group Study 213
R J Wells, D C Arthur, A Srivastava, et al.
Vox Sanguinis
|
December 17, 2013
Should DEHP be eliminated in blood bags?
P F van der Meer, H W Reesink, S Panzer, et al.
Journal of Medicinal Chemistry
|
August 30, 2023
Pharmacology and Therapeutic Potential of Benzothiazole Analogues for Cocaine Use Disorder
Comfort A Boateng, Ashley N Nilson, Rebekah Placide, et al.
The New England Journal of Medicine
|
August 11, 2016
Treatment of Fabry's Disease with the Pharmacologic Chaperone Migalastat
Dominique P Germain, Derralynn A Hughes, Kathleen Nicholls, et al.
Journal of Medical Genetics
|
November 12, 2016
Oral pharmacological chaperone migalastat compared with enzyme replacement therapy in Fabry disease: 18-month results from the randomised phase III ATTRACT study
Derralynn A Hughes, Kathleen Nicholls, Suma P Shankar, et al.
Page
of 64